#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic graft versus host disease Rheumatoid arthritis Peritoneal mesothelioma malignant Congenital ectodermal dysplasia Epilepsy Netherton's syndrome Oesophageal achalasia Hairy cell leukaemia recurrent Hyperadrenocorticism Metachromatic leukodystrophy Pleural mesothelioma malignant Epidermolysis bullosa Cutaneous T-cell lymphoma refractory Chronic myeloid leukaemia Systemic mastocytosis More trials…

    Learn about Rare Diseases

    Lymphangioma – Diagnostics Myelodysplastic syndrome with excess blasts – Treatment Progressive multifocal leukoencephalopathy – Life with Disease Andersen-Tawil syndrome SAPHO syndrome – Treatment Toxic epidermal necrolysis Cystic fibrosis – Trials in Disease Prader-Willi syndrome – Trials in Disease Angiosarcoma – Trials in Disease Burkitt’s lymphoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Miransertib Golexanolone SAR443820 Methadone Hydrochloride Ociperlimab Op-1250 Bay 3018250 Sodium Iodide Fluciclovine (18F) Bgb-15025 Citrate Immunoglobulin A Flecainide Acetate Brexpiprazole Fumarate ALENDRONATE SODIUM TRIHYDRATE Arginine Ulonivirine ATOVAQUONE Efmoroctocog Alfa Fosaprepitant Methyl Aminolevulinate More therapies…

    Learn about Your Condition

    Pharyngeal cancer stage I Giardiasis Oropharyngeal cancer recurrent Retinopathy of prematurity Skin disorder Infertility female Leber's congenital amaurosis Noninfective chorioretinitis Bone hypertrophy Choroidal neovascularisation Adrenoleukodystrophy Hypoparathyroidism Angelman's syndrome Bacterial vaginosis Impaired gastric emptying More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on the Effectiveness and Safety of Dupilumab for Adults with Chronic Itch of Unknown Cause

    Recruiting

    3 1 1
    Investigated Diseases:
    • Pruritus
    Investigated Drugs:
    • Dupilumab
    • Fexofenadine
    • Loratadine
    France Germany Hungary Italy Poland Spain

  • Study Comparing Survival in Patients with Advanced or Metastatic Gastric Cancer Treated with Botensilimab and Balstilimab vs. Standard Drug Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Gastric cancer
    Investigated Drugs:
    • Balstilimab
    • Botensilimab
    • Capecitabine
    France

  • Study on Anakinra and Colchicine for Painful Attacks in Familial Mediterranean Fever Patients Resistant to Colchicine Therapy

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Anakinra
    • Colchicine
    France

  • Study on Long-Term Safety of Trastuzumab Deruxtecan for Patients with Advanced HER2-Positive or HER2-Mutated Solid Tumors

    Recruiting

    3 1 1
    Investigated Diseases:
    • HER2 positive gastric cancer
    • Breast cancer metastatic
    • Non-small cell lung cancer metastatic
    Investigated Drugs:
    • Trastuzumab Deruxtecan
    Belgium France Italy Spain

  • Study on Ketamine and Midazolam for Adults with Depression and Alcohol Use Disorder

    Recruiting

    1 1 1
    Investigated Drugs:
    • Ketamine
    • Midazolam Hydrochloride
    Norway

  • Study on Valacyclovir for Preventing and Treating Cytomegalovirus (CMV) in Pregnant Women

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Cytomegalovirus infection
    Investigated Drugs:
    • Valaciclovir
    Poland
Previous Page
1 … 441 442 443 444 445 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!